Early research (Phase 1)Study completedNCT00077467
What this trial is testing
Bortezomib in Treating Young Patients With Refractory or Recurrent Leukemia
Who this might be right for
Blastic Phase Chronic Myelogenous LeukemiaChildhood Acute Promyelocytic Leukemia (M3)Recurrent Childhood Acute Lymphoblastic Leukemia+1 more
National Cancer Institute (NCI) 36